Plenapausa

Cover Block

PUBLIC

Name	Plenapausa
Tagline	Brazilian femtech for menopause: info, community, supplements, personalized care.
Headquarters	São Paulo, Brazil
Founded	2021
Stage	Pre-Seed
Business Model	Direct-to-Consumer (DTC)
Industry	Healthtech
Technology	AI / Machine Learning
Geography	Latin America
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)
Funding Label	Undisclosed

Links

PUBLIC

• Website: https://plenapausa.com.br/
• LinkedIn: https://br.linkedin.com/company/plenapausa

Executive Summary

PUBLIC

Plenapausa builds a digital platform for menopause care in Latin America, where cultural barriers limit access to information and treatment [MATTER, April 2023]. Founded in 2021 by Márcia Cunha and Carla Moussali, it targets practical and emotional challenges with educational content, community circles, natural supplements, and personalized journeys including online triage and AI support [Perplexity Sonar Pro Brief].

The founders combine psychological and legal expertise with entrepreneurial experience. Neither has a public record of scaling a venture-backed healthtech company [ABC da Comunicação]. Selection into the 51 Labs women's health accelerator, backed by MATTER and Astellas Pharma, offers validation and growth support [MATTER, April 2023].

Key metrics to track over 12-18 months include commercial partnerships from the accelerator, funding disclosures, and traction beyond sub-$5 million revenue [Perplexity Sonar Pro Brief].

Data Accuracy: YELLOW -- Core description and accelerator confirmed; team partially corroborated; financials from single source.

Taxonomy Snapshot

Axis	Value
Stage	Pre-Seed
Business Model	Direct-to-Consumer (DTC)
Industry / Vertical	Healthtech
Technology Type	AI / Machine Learning
Geography	Latin America
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)

Company Overview

PUBLIC

Plenapausa launched in 2021 from São Paulo. Founders Márcia Cunha and Carla Moussali targeted a gap in menopause support for Brazilian women [Pequenas Empresas Grandes Negócios, Jan 2022]. It claims first-mover status in Brazilian femtech for this demographic, with four pillars: information, community circles, supplements, and personalized journeys [MATTER, April 2023].

Milestones include a 2022 free support group for engagement [ABC da Comunicação]. In April 2023, it joined the 51 Labs accelerator backed by MATTER, Astellas Pharma US, and Walgreens [MATTER, April 2023]. Reports note plans to expand toward comprehensive clinical care [Startups.com.br].

Data Accuracy: YELLOW -- Founding and accelerator confirmed by multiple sources. Scale and timeline less documented in English outlets.

Product and Technology

MIXED

Plenapausa organizes around four pillars for menopause care [MATTER, April 2023]. Users start with online triage for symptoms, leading to personalized plans with supplements, community circles, and asynchronous AI support [Perplexity Sonar Pro Brief].

The direct-to-consumer model targets discreet solutions. Plans adapt to changing needs [Perplexity Sonar Pro Brief]. It blends digital platform with e-commerce for supplements. No formal telehealth or prescriptions announced.

Data Accuracy: YELLOW -- Pillars from accelerator; AI and triage from one brief. Stack and roadmap not public.

Market Research and Opportunity

PUBLIC

The global femtech market hit $40 billion in 2022. Projections show growth from chronic care and wellness [CB Insights]. Menopause forms a fast-growing part.

Brazil lacks segmented sizing. Plenapausa eyes a billion-dollar slice [Plenapausa]. By 2025, over one billion women worldwide face menopause or post-menopause, with income and frustration over stigma [LinkedIn]. Brazil adds limited specialized care.

Drivers include digital health adoption and holistic wellness shifts. Adjacent markets: telemedicine, nutraceuticals, corporate wellness. Watch Brazil's digital health and supplement rules.

Metric	Value
Global Femtech Market (2022)	40 $B
Company Target Market	1 $B (est.)

The table shows the category scale. Plenapausa's ambition fits the population, though Brazil needs diligence.

Data Accuracy: YELLOW -- Company ambition public; femtech from analysts. Regional TAM uncorroborated.

Competitive Landscape

MIXED

Plenapausa leads in Brazilian menopause femtech.

• Direct peer. Ilka, another Brazilian femtech, competes for mindshare [public reporting].
• Adjacent substitutes. Gynecologists offer HRT; platforms like Dr. Consulta or Alice cover broader women's health.
• International. U.S. players like Evernow or Elektra Health have not entered Brazil publicly.

Its edge: early focus and 51 Labs selection for credibility and networks [MATTER, April 2023]. The four-pillar model aids trust [MATTER, April 2023]. This moat fades without execution.

Risks: outscaled by platforms adding modules; DTC faces pharmacy rivals like Drogasil.

In 18 months, seed funding and partnerships could lock position. Otherwise, rivals like Ilka may erode advantage.

Data Accuracy: YELLOW -- Ilka named but positioning sparse. Analysis from model and landscape.

Opportunity

PUBLIC Plenapausa eyes dominance in Brazilian menopause care for an underserved group.

It leads as first Brazilian femtech with triage, community, products, journeys [MATTER, April 2023]. 51 Labs aids partnerships [Perplexity Sonar Pro Brief]. The stigma-reducing approach fits fragmented care.

Growth paths vary.

Scenario	What happens	Catalyst	Why it's plausible
Integrated Care Platform	Evolves to full virtual care with prescriptions, referrals.	Partnerships with insurers or wellness programs.	Ambition as "Dr. Consulta for menopause" [Startups.com.br]; U.S. blueprint.
Regional Category Leader	Expands to LatAm Portuguese/Spanish markets.	Regional investor.	Global gap needs local context; language edge.
Data-Driven Supplement & Protocol Leader	Builds IP from user data for formulations.	Clinical study partnership.	AI plans generate symptom data [Perplexity Sonar Pro Brief].

Community flywheel: users advocate, data improves AI, boosts retention [ABC da Comunicação]. Comps suggest hundreds of millions possible, per digital health multiples.

Data Accuracy: YELLOW -- First-mover from accelerator [MATTER, April 2023]. Scenarios from model.

Sources

PUBLIC

1. [MATTER, April 2023] April 2023: Meet the newest members of the MATTER startup community | https://matter.health/posts/april-2023-meet-the-newest-members-of-the-matter-startup-community/

2. [Pequenas Empresas Grandes Negócios, Jan 2022] Empreendedoras criam femtech para promover acolhimento durante a menopausa | https://revistapegn.globo.com/Startups/noticia/2022/01/empreendedoras-criam-femtech-para-promover-acolhimento-durante-menopausa.html

3. [Perplexity Sonar Pro Brief] Plenapausa: Research Brief |

4. [ABC da Comunicação] Plenapausa cria grupo gratuito de acolhimento para as mulheres em menopausa | https://www.abcdacomunicacao.com.br/plenapausa-cria-grupo-gratuito-de-acolhimento-para-as-mulheres-em-menopausa/

5. [Startups.com.br] Plenapausa amplia modelo para ser Dr. Consulta da menopausa - Startups | https://startups.com.br/negocios/femtech/plenapausa-amplia-modelo-para-ser-dr-consulta-da-menopausa/

6. [Plenapausa] Startup busca fatia no bilionário mercado da menopausa - Plenapausa | https://plenapausa.com.br/startup-busca-fatia-no-bilionario-mercado-da-menopausa/

7. [LinkedIn] Plenapausa | LinkedIn | https://br.linkedin.com/company/plenapausa

8. [CB Insights] Plenapausa - Products, Competitors, Financials, Employees, Headquarters Locations | https://www.cbinsights.com/company/plenapausa